 Cathy Bradley
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 62 | 2024 | 2179 | 10.960 |
Why?
| | Employment | 37 | 2024 | 135 | 10.500 |
Why?
| | Medicaid | 37 | 2023 | 411 | 9.130 |
Why?
| | Breast Neoplasms | 47 | 2023 | 1965 | 6.300 |
Why?
| | Cancer Survivors | 13 | 2023 | 201 | 5.020 |
Why?
| | Insurance Coverage | 20 | 2023 | 208 | 4.630 |
Why?
| | Insurance, Health | 19 | 2023 | 244 | 4.310 |
Why?
| | Medicare | 34 | 2023 | 663 | 3.970 |
Why?
| | SEER Program | 21 | 2022 | 205 | 3.440 |
Why?
| | Poverty | 13 | 2022 | 444 | 3.370 |
Why?
| | Healthcare Disparities | 14 | 2020 | 496 | 3.010 |
Why?
| | Cost of Illness | 13 | 2022 | 258 | 2.980 |
Why?
| | Medically Uninsured | 12 | 2020 | 125 | 2.850 |
Why?
| | Colorectal Neoplasms | 15 | 2022 | 628 | 2.850 |
Why?
| | Uterine Cervical Neoplasms | 7 | 2020 | 216 | 2.700 |
Why?
| | United States | 89 | 2023 | 12555 | 2.570 |
Why?
| | Early Detection of Cancer | 9 | 2022 | 360 | 2.430 |
Why?
| | Survivors | 16 | 2022 | 418 | 2.350 |
Why?
| | Registries | 31 | 2023 | 1810 | 2.260 |
Why?
| | Health Services Accessibility | 16 | 2023 | 781 | 2.230 |
Why?
| | Health Benefit Plans, Employee | 5 | 2022 | 20 | 2.130 |
Why?
| | Caregivers | 6 | 2023 | 709 | 1.940 |
Why?
| | Humans | 186 | 2024 | 118972 | 1.910 |
Why?
| | Survivorship | 4 | 2022 | 38 | 1.890 |
Why?
| | Health Care Costs | 13 | 2022 | 394 | 1.880 |
Why?
| | Health Care Reform | 4 | 2021 | 95 | 1.680 |
Why?
| | Antineoplastic Agents | 8 | 2020 | 1974 | 1.630 |
Why?
| | Medical Oncology | 5 | 2023 | 229 | 1.610 |
Why?
| | Drug Costs | 3 | 2023 | 94 | 1.580 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 5 | 2020 | 968 | 1.550 |
Why?
| | Colonic Neoplasms | 5 | 2016 | 224 | 1.480 |
Why?
| | Mental Health | 4 | 2023 | 568 | 1.470 |
Why?
| | Aged | 69 | 2023 | 19657 | 1.440 |
Why?
| | Female | 118 | 2023 | 61564 | 1.430 |
Why?
| | Socioeconomic Factors | 20 | 2022 | 1129 | 1.380 |
Why?
| | Policy | 4 | 2024 | 133 | 1.370 |
Why?
| | Michigan | 24 | 2015 | 95 | 1.360 |
Why?
| | Research | 6 | 2022 | 411 | 1.360 |
Why?
| | Lung Neoplasms | 10 | 2020 | 2220 | 1.310 |
Why?
| | Middle Aged | 69 | 2023 | 27617 | 1.300 |
Why?
| | Prescription Drugs | 2 | 2023 | 113 | 1.270 |
Why?
| | Prostatic Neoplasms | 10 | 2022 | 940 | 1.260 |
Why?
| | Neoplasm Staging | 17 | 2022 | 1223 | 1.260 |
Why?
| | Income | 7 | 2023 | 173 | 1.220 |
Why?
| | Health Status Disparities | 2 | 2023 | 209 | 1.220 |
Why?
| | Health Status | 10 | 2013 | 726 | 1.200 |
Why?
| | Medical Record Linkage | 2 | 2021 | 53 | 1.150 |
Why?
| | Papanicolaou Test | 2 | 2017 | 40 | 1.110 |
Why?
| | Aged, 80 and over | 35 | 2020 | 6561 | 1.100 |
Why?
| | Male | 86 | 2022 | 57801 | 1.080 |
Why?
| | Primary Health Care | 6 | 2023 | 1560 | 1.070 |
Why?
| | Motivation | 2 | 2020 | 506 | 1.050 |
Why?
| | Efficiency | 6 | 2016 | 89 | 1.030 |
Why?
| | Patient Acceptance of Health Care | 4 | 2018 | 687 | 1.020 |
Why?
| | Adult | 60 | 2023 | 31512 | 1.010 |
Why?
| | Safety-net Providers | 3 | 2017 | 96 | 1.010 |
Why?
| | Eligibility Determination | 5 | 2018 | 55 | 0.940 |
Why?
| | Comorbidity | 12 | 2019 | 1527 | 0.920 |
Why?
| | Mass Screening | 10 | 2022 | 1052 | 0.920 |
Why?
| | Colonoscopy | 4 | 2019 | 208 | 0.910 |
Why?
| | Health Expenditures | 8 | 2023 | 174 | 0.890 |
Why?
| | Return to Work | 4 | 2022 | 22 | 0.870 |
Why?
| | Absenteeism | 4 | 2013 | 38 | 0.870 |
Why?
| | Virginia | 7 | 2018 | 52 | 0.830 |
Why?
| | Quality of Life | 5 | 2019 | 2366 | 0.830 |
Why?
| | Workplace | 4 | 2021 | 222 | 0.810 |
Why?
| | Health Equity | 1 | 2022 | 56 | 0.800 |
Why?
| | Cancer Care Facilities | 3 | 2023 | 35 | 0.760 |
Why?
| | Medication Adherence | 2 | 2023 | 556 | 0.750 |
Why?
| | Perioperative Care | 1 | 2021 | 132 | 0.740 |
Why?
| | Cost Sharing | 1 | 2020 | 14 | 0.740 |
Why?
| | Models, Economic | 2 | 2011 | 48 | 0.730 |
Why?
| | Information Dissemination | 1 | 2022 | 210 | 0.710 |
Why?
| | Chemotherapy, Adjuvant | 7 | 2023 | 360 | 0.690 |
Why?
| | Mammography | 3 | 2014 | 126 | 0.680 |
Why?
| | Preventive Health Services | 5 | 2023 | 135 | 0.680 |
Why?
| | Health Planning Guidelines | 1 | 2018 | 25 | 0.670 |
Why?
| | Health Facilities | 1 | 2019 | 75 | 0.660 |
Why?
| | Spouses | 3 | 2017 | 88 | 0.660 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 294 | 0.630 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 295 | 0.630 |
Why?
| | Young Adult | 22 | 2022 | 10793 | 0.620 |
Why?
| | Survival Analysis | 10 | 2019 | 1267 | 0.620 |
Why?
| | Retirement | 4 | 2022 | 29 | 0.610 |
Why?
| | Reimbursement, Incentive | 1 | 2017 | 38 | 0.600 |
Why?
| | Job Satisfaction | 3 | 2013 | 175 | 0.580 |
Why?
| | Healthy People Programs | 1 | 2016 | 8 | 0.570 |
Why?
| | Occupational Health Services | 2 | 2016 | 31 | 0.570 |
Why?
| | Bevacizumab | 1 | 2017 | 124 | 0.570 |
Why?
| | Length of Stay | 6 | 2012 | 1032 | 0.560 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2023 | 164 | 0.560 |
Why?
| | Logistic Models | 13 | 2023 | 1901 | 0.560 |
Why?
| | Outpatients | 1 | 2019 | 325 | 0.560 |
Why?
| | Chronic Pain | 1 | 2019 | 211 | 0.550 |
Why?
| | Job Description | 2 | 2013 | 12 | 0.550 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 540 | 0.550 |
Why?
| | Massachusetts | 4 | 2021 | 141 | 0.550 |
Why?
| | Rectal Neoplasms | 1 | 2016 | 121 | 0.520 |
Why?
| | Nursing Homes | 4 | 2013 | 130 | 0.520 |
Why?
| | State Government | 3 | 2014 | 41 | 0.510 |
Why?
| | Fee-for-Service Plans | 4 | 2023 | 79 | 0.510 |
Why?
| | Vaginal Smears | 1 | 2014 | 49 | 0.500 |
Why?
| | Longitudinal Studies | 10 | 2022 | 2513 | 0.480 |
Why?
| | Mouth Neoplasms | 3 | 2019 | 79 | 0.480 |
Why?
| | Emergency Treatment | 1 | 2015 | 110 | 0.470 |
Why?
| | General Practice | 1 | 2014 | 26 | 0.470 |
Why?
| | Health Personnel | 3 | 2022 | 588 | 0.470 |
Why?
| | Health Services Research | 4 | 2010 | 385 | 0.470 |
Why?
| | Sick Leave | 2 | 2019 | 12 | 0.460 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 1390 | 0.460 |
Why?
| | Delivery of Health Care | 5 | 2024 | 867 | 0.460 |
Why?
| | Databases, Factual | 7 | 2021 | 1231 | 0.450 |
Why?
| | Behavioral Risk Factor Surveillance System | 4 | 2017 | 44 | 0.450 |
Why?
| | Sickness Impact Profile | 1 | 2013 | 51 | 0.450 |
Why?
| | Cost-Benefit Analysis | 8 | 2017 | 554 | 0.440 |
Why?
| | Insurance Claim Review | 2 | 2010 | 67 | 0.430 |
Why?
| | Homes for the Aged | 2 | 2013 | 19 | 0.430 |
Why?
| | Marital Status | 3 | 2007 | 43 | 0.430 |
Why?
| | Value of Life | 2 | 2008 | 19 | 0.420 |
Why?
| | Survival Rate | 7 | 2020 | 1720 | 0.420 |
Why?
| | Work | 3 | 2010 | 18 | 0.420 |
Why?
| | Age Factors | 11 | 2022 | 2995 | 0.410 |
Why?
| | Quality Improvement | 2 | 2018 | 963 | 0.410 |
Why?
| | Neoplasm Metastasis | 3 | 2020 | 544 | 0.410 |
Why?
| | Cross-Sectional Studies | 11 | 2023 | 4552 | 0.400 |
Why?
| | Risk Factors | 13 | 2021 | 9000 | 0.390 |
Why?
| | Periodicals as Topic | 2 | 2023 | 191 | 0.390 |
Why?
| | Health Services | 1 | 2012 | 110 | 0.390 |
Why?
| | Social Class | 4 | 2022 | 218 | 0.380 |
Why?
| | Surgical Procedures, Operative | 2 | 2012 | 215 | 0.380 |
Why?
| | Physician Self-Referral | 1 | 2010 | 1 | 0.380 |
Why?
| | Intestinal Perforation | 3 | 2016 | 41 | 0.370 |
Why?
| | Biomedical Research | 2 | 2020 | 612 | 0.360 |
Why?
| | Financing, Personal | 2 | 2019 | 27 | 0.360 |
Why?
| | Physicians | 1 | 2018 | 794 | 0.350 |
Why?
| | Waiting Lists | 1 | 2011 | 228 | 0.350 |
Why?
| | Gastrointestinal Hemorrhage | 3 | 2016 | 109 | 0.350 |
Why?
| | Recovery of Function | 1 | 2013 | 604 | 0.350 |
Why?
| | Radiation Oncology | 1 | 2010 | 76 | 0.350 |
Why?
| | Astrocytoma | 1 | 2010 | 113 | 0.350 |
Why?
| | Costs and Cost Analysis | 2 | 2022 | 202 | 0.350 |
Why?
| | Data Collection | 3 | 2014 | 658 | 0.340 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2019 | 610 | 0.340 |
Why?
| | Administration, Oral | 2 | 2023 | 756 | 0.340 |
Why?
| | Surveys and Questionnaires | 11 | 2018 | 4708 | 0.340 |
Why?
| | Propensity Score | 1 | 2010 | 242 | 0.340 |
Why?
| | Dentists | 1 | 2008 | 20 | 0.330 |
Why?
| | Life Expectancy | 1 | 2008 | 52 | 0.330 |
Why?
| | Persuasive Communication | 1 | 2008 | 13 | 0.330 |
Why?
| | Dental Care | 1 | 2008 | 28 | 0.330 |
Why?
| | HIV Infections | 2 | 2022 | 2459 | 0.320 |
Why?
| | Oropharyngeal Neoplasms | 2 | 2018 | 51 | 0.320 |
Why?
| | Multivariate Analysis | 9 | 2019 | 1474 | 0.310 |
Why?
| | Odds Ratio | 9 | 2014 | 996 | 0.310 |
Why?
| | Pneumonectomy | 1 | 2008 | 115 | 0.300 |
Why?
| | Models, Econometric | 5 | 2017 | 34 | 0.300 |
Why?
| | Communication | 2 | 2019 | 761 | 0.300 |
Why?
| | Depression | 4 | 2021 | 1132 | 0.300 |
Why?
| | Patient Education as Topic | 1 | 2011 | 699 | 0.290 |
Why?
| | Likelihood Functions | 5 | 2021 | 136 | 0.280 |
Why?
| | Confidence Intervals | 4 | 2013 | 324 | 0.280 |
Why?
| | Quality-Adjusted Life Years | 4 | 2017 | 103 | 0.270 |
Why?
| | Time Factors | 11 | 2013 | 6412 | 0.270 |
Why?
| | Education, Medical, Graduate | 1 | 2010 | 399 | 0.270 |
Why?
| | Online Systems | 1 | 2005 | 26 | 0.270 |
Why?
| | Anxiety | 3 | 2021 | 845 | 0.260 |
Why?
| | Colonic Diseases | 2 | 2016 | 26 | 0.260 |
Why?
| | Myocardial Infarction | 3 | 2023 | 968 | 0.260 |
Why?
| | Referral and Consultation | 1 | 2010 | 648 | 0.260 |
Why?
| | Cross Infection | 2 | 2017 | 205 | 0.260 |
Why?
| | Cost Savings | 2 | 2018 | 77 | 0.260 |
Why?
| | Disability Evaluation | 1 | 2007 | 280 | 0.260 |
Why?
| | Cohort Studies | 7 | 2023 | 5116 | 0.260 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2014 | 2174 | 0.250 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2011 | 532 | 0.250 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 2 | 2017 | 190 | 0.250 |
Why?
| | Health Services Needs and Demand | 3 | 2017 | 254 | 0.250 |
Why?
| | Needs Assessment | 2 | 2024 | 327 | 0.250 |
Why?
| | Models, Statistical | 4 | 2017 | 636 | 0.240 |
Why?
| | Substance-Related Disorders | 3 | 1997 | 971 | 0.240 |
Why?
| | Physician-Patient Relations | 1 | 2008 | 490 | 0.230 |
Why?
| | Hospitals, Public | 1 | 2023 | 24 | 0.230 |
Why?
| | Head and Neck Neoplasms | 2 | 2019 | 471 | 0.230 |
Why?
| | Staphylococcal Infections | 2 | 2017 | 346 | 0.220 |
Why?
| | Colorado | 2 | 2023 | 4196 | 0.220 |
Why?
| | Forecasting | 5 | 2016 | 353 | 0.220 |
Why?
| | Economics, Medical | 1 | 2022 | 4 | 0.220 |
Why?
| | Intensive Care Units | 2 | 2017 | 635 | 0.220 |
Why?
| | Carcinoma | 2 | 2017 | 204 | 0.220 |
Why?
| | Hormones | 1 | 2023 | 135 | 0.220 |
Why?
| | Age Distribution | 4 | 2020 | 362 | 0.220 |
Why?
| | Colonic Polyps | 2 | 2014 | 70 | 0.220 |
Why?
| | Risk Assessment | 6 | 2022 | 3057 | 0.210 |
Why?
| | Bisexuality | 1 | 2022 | 16 | 0.210 |
Why?
| | Analgesics, Opioid | 2 | 2021 | 794 | 0.210 |
Why?
| | Proportional Hazards Models | 5 | 2019 | 1125 | 0.210 |
Why?
| | Food Supply | 1 | 2022 | 64 | 0.210 |
Why?
| | Health Behavior | 2 | 2019 | 720 | 0.210 |
Why?
| | Incidence | 5 | 2022 | 2424 | 0.210 |
Why?
| | Hospital Charges | 3 | 2003 | 42 | 0.210 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2021 | 900 | 0.210 |
Why?
| | Brain Neoplasms | 1 | 2010 | 1022 | 0.210 |
Why?
| | Treatment Outcome | 10 | 2019 | 9342 | 0.210 |
Why?
| | Smoking | 2 | 2019 | 1487 | 0.200 |
Why?
| | Hospitalization | 5 | 2016 | 1785 | 0.200 |
Why?
| | Evidence-Based Medicine | 2 | 2016 | 693 | 0.190 |
Why?
| | Decision Making | 2 | 2005 | 809 | 0.190 |
Why?
| | Homosexuality, Male | 1 | 2022 | 166 | 0.190 |
Why?
| | Internet | 1 | 2005 | 633 | 0.190 |
Why?
| | Sex Factors | 5 | 2022 | 1781 | 0.190 |
Why?
| | Kentucky | 1 | 2020 | 36 | 0.190 |
Why?
| | Retrospective Studies | 12 | 2021 | 12978 | 0.190 |
Why?
| | Delayed Diagnosis | 1 | 2020 | 79 | 0.190 |
Why?
| | Population Surveillance | 2 | 2022 | 413 | 0.180 |
Why?
| | California | 2 | 2018 | 382 | 0.180 |
Why?
| | Benzodiazepines | 1 | 2021 | 122 | 0.180 |
Why?
| | Stress, Psychological | 2 | 2021 | 972 | 0.180 |
Why?
| | Probability | 4 | 2023 | 305 | 0.180 |
Why?
| | Carrier State | 2 | 2017 | 57 | 0.180 |
Why?
| | Sample Size | 1 | 2000 | 133 | 0.180 |
Why?
| | Ownership | 2 | 2010 | 79 | 0.180 |
Why?
| | Regression Analysis | 5 | 2021 | 983 | 0.180 |
Why?
| | Adolescent | 12 | 2020 | 18480 | 0.170 |
Why?
| | Infection Control | 2 | 2017 | 135 | 0.170 |
Why?
| | Activities of Daily Living | 2 | 2010 | 354 | 0.170 |
Why?
| | Language Development Disorders | 1 | 2019 | 40 | 0.170 |
Why?
| | Patient Selection | 3 | 2010 | 676 | 0.170 |
Why?
| | Diabetes Mellitus | 3 | 2018 | 942 | 0.170 |
Why?
| | Los Angeles | 2 | 2015 | 60 | 0.170 |
Why?
| | Anthracyclines | 3 | 2023 | 41 | 0.170 |
Why?
| | National Cancer Institute (U.S.) | 3 | 2023 | 43 | 0.170 |
Why?
| | Cancer Pain | 1 | 2018 | 20 | 0.160 |
Why?
| | Taxoids | 3 | 2023 | 98 | 0.160 |
Why?
| | Infant, Newborn | 4 | 2020 | 5255 | 0.160 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2019 | 189 | 0.160 |
Why?
| | Carboplatin | 1 | 2018 | 142 | 0.160 |
Why?
| | Cetuximab | 1 | 2018 | 99 | 0.160 |
Why?
| | Ireland | 2 | 2016 | 25 | 0.160 |
Why?
| | Hyperlipidemias | 1 | 2019 | 128 | 0.160 |
Why?
| | Inpatients | 2 | 2012 | 388 | 0.160 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2019 | 387 | 0.160 |
Why?
| | Financing, Government | 1 | 2017 | 40 | 0.150 |
Why?
| | Unemployment | 2 | 2009 | 42 | 0.150 |
Why?
| | Managed Care Programs | 1 | 2018 | 135 | 0.150 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2015 | 102 | 0.150 |
Why?
| | Patient Discharge | 1 | 2023 | 796 | 0.150 |
Why?
| | Public Health Practice | 1 | 2017 | 62 | 0.150 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 58 | 0.150 |
Why?
| | Cisplatin | 1 | 2018 | 271 | 0.150 |
Why?
| | Hypoglycemic Agents | 2 | 2018 | 1032 | 0.150 |
Why?
| | Patient Rights | 2 | 2019 | 10 | 0.150 |
Why?
| | Hospital Costs | 2 | 2011 | 110 | 0.150 |
Why?
| | Combined Modality Therapy | 4 | 2019 | 1166 | 0.150 |
Why?
| | Psychiatric Department, Hospital | 1 | 1996 | 18 | 0.150 |
Why?
| | Language | 1 | 2019 | 271 | 0.140 |
Why?
| | Heart Failure | 2 | 2023 | 1969 | 0.140 |
Why?
| | Child Behavior | 1 | 1998 | 212 | 0.140 |
Why?
| | Drug Therapy | 1 | 2017 | 76 | 0.140 |
Why?
| | Sex Distribution | 3 | 2020 | 351 | 0.140 |
Why?
| | Clinical Competence | 2 | 2014 | 951 | 0.140 |
Why?
| | Self Efficacy | 1 | 2019 | 366 | 0.140 |
Why?
| | Lymph Nodes | 1 | 2019 | 455 | 0.140 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2016 | 50 | 0.140 |
Why?
| | Smoking Cessation | 1 | 2019 | 360 | 0.140 |
Why?
| | Child, Preschool | 4 | 2020 | 9491 | 0.140 |
Why?
| | Neonatal Abstinence Syndrome | 1 | 1996 | 16 | 0.140 |
Why?
| | Residence Characteristics | 2 | 2008 | 299 | 0.130 |
Why?
| | Patient Admission | 1 | 1997 | 176 | 0.130 |
Why?
| | Colorectal Surgery | 1 | 2015 | 22 | 0.130 |
Why?
| | Minority Groups | 1 | 2017 | 237 | 0.130 |
Why?
| | Follow-Up Studies | 6 | 2019 | 4596 | 0.130 |
Why?
| | Child Development | 1 | 2019 | 410 | 0.130 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2015 | 143 | 0.130 |
Why?
| | Metformin | 1 | 2018 | 295 | 0.130 |
Why?
| | Infant | 3 | 2020 | 8293 | 0.120 |
Why?
| | Autism Spectrum Disorder | 1 | 2019 | 323 | 0.120 |
Why?
| | Mastectomy, Segmental | 3 | 2009 | 91 | 0.120 |
Why?
| | National Health Programs | 1 | 2014 | 21 | 0.120 |
Why?
| | Research Design | 3 | 2007 | 969 | 0.120 |
Why?
| | Pilot Projects | 3 | 2021 | 1419 | 0.120 |
Why?
| | Systems Integration | 1 | 2013 | 42 | 0.120 |
Why?
| | Intensive Care Units, Neonatal | 1 | 1996 | 178 | 0.120 |
Why?
| | Cerebrovascular Disorders | 1 | 2014 | 86 | 0.120 |
Why?
| | Health Status Indicators | 1 | 2014 | 154 | 0.120 |
Why?
| | Computer Simulation | 2 | 2023 | 922 | 0.110 |
Why?
| | Helping Behavior | 1 | 2013 | 15 | 0.110 |
Why?
| | Prospective Studies | 3 | 2017 | 6471 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 3 | 2021 | 842 | 0.110 |
Why?
| | Quality of Health Care | 2 | 2008 | 586 | 0.110 |
Why?
| | Occupations | 1 | 2012 | 37 | 0.110 |
Why?
| | Maryland | 3 | 1997 | 36 | 0.110 |
Why?
| | Medical Audit | 1 | 2013 | 75 | 0.110 |
Why?
| | Mandatory Programs | 1 | 2012 | 16 | 0.110 |
Why?
| | Pregnancy, Unwanted | 1 | 2012 | 13 | 0.110 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2012 | 21 | 0.110 |
Why?
| | Life Tables | 2 | 2008 | 17 | 0.110 |
Why?
| | Child | 6 | 2020 | 19129 | 0.110 |
Why?
| | Cost Control | 1 | 2012 | 44 | 0.110 |
Why?
| | Cause of Death | 1 | 2014 | 380 | 0.110 |
Why?
| | Goals | 2 | 2023 | 167 | 0.110 |
Why?
| | Attitude to Health | 2 | 2019 | 410 | 0.100 |
Why?
| | Self Disclosure | 1 | 2011 | 60 | 0.100 |
Why?
| | Contraception Behavior | 1 | 2012 | 81 | 0.100 |
Why?
| | Community Health Services | 1 | 2013 | 212 | 0.100 |
Why?
| | Mental Disorders | 2 | 1997 | 939 | 0.100 |
Why?
| | Contraceptive Agents, Female | 1 | 2012 | 65 | 0.100 |
Why?
| | Sepsis | 1 | 2017 | 531 | 0.100 |
Why?
| | Educational Status | 1 | 2013 | 437 | 0.100 |
Why?
| | Retreatment | 1 | 2011 | 71 | 0.100 |
Why?
| | Video Recording | 1 | 2011 | 156 | 0.100 |
Why?
| | Mastectomy | 1 | 2011 | 124 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 1996 | 448 | 0.100 |
Why?
| | Economics, Nursing | 1 | 2010 | 1 | 0.090 |
Why?
| | Interinstitutional Relations | 1 | 2010 | 55 | 0.090 |
Why?
| | Reproducibility of Results | 3 | 2010 | 2874 | 0.090 |
Why?
| | Stress, Physiological | 1 | 2013 | 415 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2014 | 523 | 0.090 |
Why?
| | Access to Information | 1 | 2010 | 53 | 0.090 |
Why?
| | Consumer Behavior | 1 | 1990 | 64 | 0.090 |
Why?
| | Bone Marrow Transplantation | 1 | 2011 | 244 | 0.090 |
Why?
| | Sentinel Surveillance | 1 | 2009 | 39 | 0.090 |
Why?
| | Standard of Care | 1 | 2010 | 63 | 0.090 |
Why?
| | Occult Blood | 1 | 2009 | 27 | 0.090 |
Why?
| | Comparative Effectiveness Research | 1 | 2010 | 132 | 0.090 |
Why?
| | Insurance Claim Reporting | 1 | 2009 | 24 | 0.090 |
Why?
| | Ohio | 1 | 2009 | 141 | 0.090 |
Why?
| | Sex Characteristics | 2 | 2022 | 671 | 0.090 |
Why?
| | Women's Health | 2 | 2012 | 274 | 0.090 |
Why?
| | Private Sector | 1 | 2009 | 51 | 0.090 |
Why?
| | Psychometrics | 1 | 2013 | 631 | 0.090 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2009 | 61 | 0.090 |
Why?
| | Exercise | 1 | 2019 | 1657 | 0.090 |
Why?
| | Bias | 1 | 2010 | 198 | 0.080 |
Why?
| | Home Nursing | 1 | 2008 | 27 | 0.080 |
Why?
| | Physical Exertion | 1 | 2010 | 222 | 0.080 |
Why?
| | Linear Models | 1 | 2011 | 827 | 0.080 |
Why?
| | Reimbursement Mechanisms | 1 | 2009 | 79 | 0.080 |
Why?
| | Models, Theoretical | 1 | 2013 | 556 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2013 | 610 | 0.080 |
Why?
| | Education, Professional | 1 | 2008 | 18 | 0.080 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 336 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2010 | 546 | 0.080 |
Why?
| | Radiotherapy | 1 | 2008 | 187 | 0.080 |
Why?
| | Pain | 2 | 2010 | 735 | 0.080 |
Why?
| | Self Care | 1 | 2010 | 357 | 0.080 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 525 | 0.070 |
Why?
| | Leukemia | 1 | 2008 | 208 | 0.070 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2006 | 115 | 0.070 |
Why?
| | Lung Diseases | 1 | 2012 | 718 | 0.070 |
Why?
| | Charities | 1 | 2005 | 9 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2010 | 529 | 0.070 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 1137 | 0.070 |
Why?
| | Empirical Research | 1 | 2005 | 25 | 0.060 |
Why?
| | Hospice Care | 1 | 2007 | 174 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2019 | 3171 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1244 | 0.060 |
Why?
| | Diagnosis-Related Groups | 1 | 2003 | 30 | 0.060 |
Why?
| | Pennsylvania | 1 | 2023 | 101 | 0.060 |
Why?
| | Florida | 2 | 2014 | 73 | 0.060 |
Why?
| | Resource Allocation | 1 | 2003 | 38 | 0.060 |
Why?
| | Pandemics | 2 | 2022 | 1355 | 0.060 |
Why?
| | Prevalence | 1 | 2010 | 2326 | 0.060 |
Why?
| | Health Surveys | 2 | 2007 | 454 | 0.060 |
Why?
| | Causality | 1 | 2023 | 109 | 0.060 |
Why?
| | Interviews as Topic | 1 | 2005 | 599 | 0.060 |
Why?
| | Women, Working | 1 | 2002 | 9 | 0.060 |
Why?
| | Selection Bias | 1 | 2002 | 35 | 0.060 |
Why?
| | Markov Chains | 2 | 2017 | 118 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 660 | 0.050 |
Why?
| | Sampling Studies | 1 | 2002 | 92 | 0.050 |
Why?
| | Mastectomy, Radical | 1 | 2001 | 2 | 0.050 |
Why?
| | Palliative Care | 1 | 2007 | 629 | 0.050 |
Why?
| | Pancreatic Neoplasms | 1 | 2008 | 734 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2023 | 277 | 0.050 |
Why?
| | Family Characteristics | 1 | 2002 | 156 | 0.050 |
Why?
| | Normal Distribution | 1 | 2000 | 24 | 0.050 |
Why?
| | Drug Evaluation | 1 | 2000 | 81 | 0.050 |
Why?
| | Diffusion of Innovation | 1 | 2001 | 98 | 0.050 |
Why?
| | Clinical Trials as Topic | 1 | 2004 | 969 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2008 | 2674 | 0.040 |
Why?
| | Nursing Research | 1 | 2000 | 38 | 0.040 |
Why?
| | Presenteeism | 1 | 2019 | 5 | 0.040 |
Why?
| | Etidronic Acid | 1 | 1998 | 3 | 0.040 |
Why?
| | Alendronate | 1 | 1998 | 7 | 0.040 |
Why?
| | Informed Consent | 1 | 2000 | 163 | 0.040 |
Why?
| | Federal Government | 1 | 2018 | 26 | 0.040 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 1998 | 38 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 387 | 0.040 |
Why?
| | Controlled Before-After Studies | 1 | 2017 | 16 | 0.040 |
Why?
| | Lymph Node Excision | 1 | 2019 | 158 | 0.040 |
Why?
| | Lymphatic Metastasis | 1 | 2019 | 307 | 0.040 |
Why?
| | Smoking Prevention | 1 | 1998 | 150 | 0.040 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 117 | 0.040 |
Why?
| | Tennessee | 1 | 2017 | 44 | 0.040 |
Why?
| | Spinal Fractures | 1 | 1998 | 77 | 0.040 |
Why?
| | Puberty | 1 | 1998 | 144 | 0.040 |
Why?
| | Ecosystem | 1 | 2022 | 555 | 0.040 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 1997 | 36 | 0.040 |
Why?
| | Chemoradiotherapy | 1 | 2018 | 200 | 0.040 |
Why?
| | Patient Isolation | 1 | 2017 | 19 | 0.040 |
Why?
| | Catheter-Related Infections | 1 | 2017 | 60 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2002 | 513 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2017 | 190 | 0.040 |
Why?
| | Patient Dropouts | 1 | 1997 | 66 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2017 | 49 | 0.040 |
Why?
| | Utilization Review | 1 | 1996 | 36 | 0.040 |
Why?
| | Bacteriological Techniques | 1 | 2017 | 66 | 0.040 |
Why?
| | Arizona | 1 | 1996 | 69 | 0.040 |
Why?
| | Health Policy | 1 | 2019 | 333 | 0.040 |
Why?
| | Anticholesteremic Agents | 1 | 2018 | 130 | 0.040 |
Why?
| | Schools | 1 | 2000 | 411 | 0.040 |
Why?
| | Dyslipidemias | 1 | 2018 | 162 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 736 | 0.040 |
Why?
| | Hospitals, Community | 1 | 1996 | 49 | 0.040 |
Why?
| | Obstetric Labor, Premature | 1 | 1996 | 38 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 462 | 0.030 |
Why?
| | Health Resources | 2 | 2009 | 132 | 0.030 |
Why?
| | Antihypertensive Agents | 1 | 2018 | 437 | 0.030 |
Why?
| | Protoporphyrins | 1 | 1993 | 17 | 0.030 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 417 | 0.030 |
Why?
| | Acute Disease | 1 | 1996 | 940 | 0.030 |
Why?
| | Lead | 1 | 1993 | 47 | 0.030 |
Why?
| | Learning Curve | 1 | 2014 | 67 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2017 | 1691 | 0.030 |
Why?
| | Sensitivity and Specificity | 3 | 2009 | 1795 | 0.030 |
Why?
| | Societies, Medical | 1 | 2016 | 703 | 0.030 |
Why?
| | Community Participation | 1 | 2013 | 120 | 0.030 |
Why?
| | General Surgery | 1 | 2014 | 134 | 0.030 |
Why?
| | Calcium | 1 | 1998 | 1169 | 0.030 |
Why?
| | Pregnancy | 2 | 2012 | 5690 | 0.030 |
Why?
| | Gastroenterology | 1 | 2014 | 158 | 0.030 |
Why?
| | Risk | 1 | 2014 | 853 | 0.030 |
Why?
| | Stroke | 1 | 2020 | 1047 | 0.030 |
Why?
| | Cooperative Behavior | 1 | 2013 | 408 | 0.020 |
Why?
| | Contraception | 1 | 2012 | 118 | 0.020 |
Why?
| | Hepatitis B | 1 | 1991 | 52 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3443 | 0.020 |
Why?
| | Work Capacity Evaluation | 1 | 2010 | 13 | 0.020 |
Why?
| | Leadership | 1 | 2013 | 311 | 0.020 |
Why?
| | Budgets | 1 | 2009 | 14 | 0.020 |
Why?
| | Sigmoidoscopy | 1 | 2009 | 10 | 0.020 |
Why?
| | Hypertension | 1 | 2018 | 1203 | 0.020 |
Why?
| | Task Performance and Analysis | 1 | 2010 | 164 | 0.020 |
Why?
| | Ambulatory Care | 1 | 2013 | 482 | 0.020 |
Why?
| | Meta-Analysis as Topic | 1 | 2009 | 164 | 0.020 |
Why?
| | Prostatectomy | 1 | 2009 | 100 | 0.020 |
Why?
| | Occupational Exposure | 1 | 1991 | 277 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 467 | 0.020 |
Why?
| | Psychology | 1 | 2008 | 84 | 0.020 |
Why?
| | Demography | 1 | 2008 | 274 | 0.020 |
Why?
| | Mortality | 1 | 2008 | 299 | 0.020 |
Why?
| | Lifting | 1 | 2006 | 6 | 0.020 |
Why?
| | Least-Squares Analysis | 1 | 2006 | 73 | 0.020 |
Why?
| | Illinois | 1 | 2006 | 38 | 0.020 |
Why?
| | Telephone | 1 | 2007 | 152 | 0.020 |
Why?
| | Patient Compliance | 1 | 2009 | 537 | 0.020 |
Why?
| | Body Weight | 1 | 1990 | 934 | 0.020 |
Why?
| | Prejudice | 1 | 2006 | 56 | 0.020 |
Why?
| | Burnout, Professional | 1 | 2010 | 330 | 0.020 |
Why?
| | Myocardial Revascularization | 1 | 2003 | 72 | 0.010 |
Why?
| | Vaccination | 1 | 1991 | 1222 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 403 | 0.010 |
Why?
| | Behavior | 1 | 2002 | 95 | 0.010 |
Why?
| | Episode of Care | 1 | 2001 | 5 | 0.010 |
Why?
| | Decision Trees | 1 | 2001 | 83 | 0.010 |
Why?
| | Drug Prescriptions | 1 | 2002 | 248 | 0.010 |
Why?
| | Cardiac Catheterization | 1 | 2003 | 541 | 0.010 |
Why?
| | Reoperation | 1 | 2001 | 557 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2002 | 1032 | 0.010 |
Why?
| | Estrogens | 1 | 1998 | 328 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1998 | 965 | 0.010 |
Why?
| | Estradiol | 1 | 1998 | 476 | 0.010 |
Why?
| | Lead Poisoning | 1 | 1993 | 18 | 0.010 |
Why?
| | ROC Curve | 1 | 1993 | 473 | 0.010 |
Why?
| | Reference Values | 1 | 1993 | 774 | 0.010 |
Why?
| | Program Evaluation | 1 | 1991 | 845 | 0.000 |
Why?
|
|
Bradley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|